La Fe University and Politechnic Hospital
Valencia, 46026, Spain
NCT Number: NCT01546064
The purpose of this study was to compare the incidence and severity of biliary complications due to liver transplantation after choledochocholedochostomy with or without a T-tube. A per-protocol analysis was designed for recipients of orthotopic liver transplantation in a single center, who were randomly assigned to choledochocholedochostomy with or without a T-tube. It is a prospective and randomized study.
Looking for future studies?
Notify Me18 year–67 year
All sexes
Interventional
Not applicable
Valencia, 46026, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the anastomosis between the common bile duct of the graft and the common bile duct of the recipient, a tutorial T-tube is inserted in the bile duct lumen and will be removed from the patient on third month postoperatively.
The termino-terminal anastomosis between common bile duct of the graft and common bile duct of the recipient is performed without any T-tube.
Time frame: The first year after liver transplantation procedure
All the complications related to bile duct that appear after transplantation will be recorded in both groups. All patients will be followed up for the first 12 months after transplantation.
Hospital Universitario La Fe
Other
Prospective and Randomized Trial on the Usefulness of T-Tube in the Bile Duct Anastomosis in Liver Transplantation Procedure.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01022476
Adenocarcinoma, Blood-Borne Infections
Le Kremlin-Bicêtre, France
View Trial DetailsNCT02263703
Arthritis, Arthritis, Juvenile
Sydney, New South Wales, Australia
View Trial DetailsNCT01208337
ALEMTUZUMAB, Behavior
View Trial DetailsNCT04763096
Evidence of Liver Transplantation
Seoul, South Korea
View Trial Details